Time-dependent C-index analysis revealed that the combination of ERO1A expression and CD163<sup>+</sup> TAM density was superior to either factor alone in predicting ccRCC patient survival. This evidence concerns the gene ERO1A and nonpapillary renal cell carcinoma.